Education
About Us
Working with TipRanks
Follow Us
Tarsus Pharmaceuticals (TARS)
NASDAQ:TARS
Earnings Data
Report Date
Mar 16, 2026After Close (Confirmed)
Period Ending
2025 (Q4)Consensus EPS Forecast
-0.1Last Year’s EPS
-0.6Same Quarter Last Year
Strong Buy
Based on 6 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Positive
The earnings call conveyed a strong positive outlook with exceptional product launch performance, robust financial results, and promising pipeline developments. However, challenges remain in managing Medicare-related discounts and rising operational costs.Company Guidance
Exceptional XDEMVY Launch Performance
Delivered more than 103,000 bottles of XDEMVY with $119 million in net revenue, marking significant growth and broad adoption by over 20,000 doctors.
Strong Financial Performance and Forecast
Revenue reached $118.7 million in Q3 with double-digit growth in both prescription volumes and revenues. Q4 net product sales are expected to be between $140 million to $145 million.
Expansion into New Therapeutic Areas
Progress in developing treatments for ocular rosacea and Lyme disease prevention, with a Phase II trial for TP-04 expected to start by the end of the year.
Significant Market Penetration and Brand Recognition
XDEMVY has been prescribed to nearly 400,000 patients, demonstrating growing acceptance. Website visits increased by 90% and unaided awareness grew by 42%.
TARS Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
TARS Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Nov 04, 2025 | $71.50 | $68.20 | -4.62% |
Aug 06, 2025 | $41.64 | $47.95 | +15.15% |
May 01, 2025 | $50.30 | $47.36 | -5.84% |
Feb 25, 2025 | $45.54 | $41.29 | -9.33% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Tarsus Pharmaceuticals (TARS) report earnings?
Tarsus Pharmaceuticals (TARS) is schdueled to report earning on Mar 16, 2026, After Close (Confirmed).
What is Tarsus Pharmaceuticals (TARS) earnings time?
Tarsus Pharmaceuticals (TARS) earnings time is at Mar 16, 2026, After Close (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is TARS EPS forecast?
TARS EPS forecast for the fiscal quarter 2025 (Q4) is -0.1.